tiprankstipranks
Trending News
More News >
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (HK:8049)
:8049

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (8049) Price & Analysis

Compare
0 Followers

8049 Stock Chart & Stats


Financials

8049 FAQ

What was Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price range in the past 12 months?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H lowest stock price was HK$1.21 and its highest was HK$2.55 in the past 12 months.
    What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap?
    Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap is HK$1.17B.
      When is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date?
      Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date is Aug 13, 2025 which is in 40 days.
        How were Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s earnings last quarter?
        Currently, no data Available
        Is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H overvalued?
        According to Wall Street analysts Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pay dividends?
          Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pays a Notavailable dividend of HK$0.273 which represents an annual dividend yield of 2.93%. See more information on Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H dividends here
            What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate?
            Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H have?
            Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 172,500,000 shares outstanding.
              What happened to Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H?
              Currently, no hedge funds are holding shares in HK:8049

              Company Description

              Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H

              Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.
              Similar Stocks
              Company
              Price & Change
              Follow
              Zhongzhi Pharmaceutical Holdings Limited
              Dawnrays Pharmaceutical Holdings Ltd.
              JBM (Healthcare) Ltd.
              Fusen Pharmaceutical Co., Ltd.
              Lee's Pharmaceutical Holdings Limited
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis